Huge Opportunity Sets Up on Small-Cap Pharma Stock

Hey Trader, April is historically one of the strongest performing months for stocks. … And that's historical data from years when we're not just coming out the other side of a global pandemic. You see, right now there's a rare convergence of several factors that are priming the markets for some potentially massive opportunities. In fact, Wharton school of business professor Jeremy Siegal said he expects the market could go up another 30%. That means that RIGHT NOW is the time to be poised and ready for action… Because those opportunities are already popping up. In fact, Ross Givens has just issued a hot new buy alert on a small-cap pharmaceutical firm that's awaiting an FDA approval as we speak. Discover how to access this trade right now… Now Ross used the exact same methodology to target this trade that he used to identify a profitable play on Apple just a few weeks ago. At the time, AAPL was caught up in the tech-led selloff caused by a rising Treasury yield. But using his powerful volume-based roadmap, Ross called an entry on the stock plus a call option play within a dollar of the low… And now, members who took this trade have seen their stock rise $24… While the options have jumped 51% in a month. Now Ross tells me he's actively scanning and vetting several more opportunities that could be triggered at any moment… So if you'd like to learn more about his unique roadmap methodology AND get your hands on this newest trade alert that he's just issued, click here to view a free on-demand training… And take advantage of the boom while you can! To your success,  Anthony Speciale Jr Hawkeye Traders team1@hawkeyetraders.com Call us: (888) 233-8598 DISCLAIMER: * Futures, stocks, and spot currency trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures, stocks, and forex markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures, stocks or forex. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. Past performance of indicators or methodology are not necessarily indicative of future results. CFTC Regulation 4.41 These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown. We'll always treat your personal information with the utmost care and will never sell it to third parties. You can find out more about what data we hold about you, why we need it, and how we keep that information safe in our Privacy Policy.

If you wish to stop receiving our emails or change your subscription options, please manage your subscription.

14422 Shoreside Way, Suite 110-160, Winter Garden, FL 3478, US